IL-8 exerts its biological effects primarily through binding to its cognate receptors, CXCR1 and CXCR2 [5], which are expressed on the surface of various cell types [6,7,8,9,10], including cancer cells and cells within the tumor microenvironment [3]. This evidence concerns the gene CXCL8 and neoplasm.